Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor

scientific article published on 01 December 1999

Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/(SICI)1097-0045(19991201)41:4<233::AID-PROS3>3.0.CO;2-L
P698PubMed publication ID10544296

P2093author name stringQ Wang
C W Lin
H T Aretz
S Tabatabaei
W S McDougal
B Planz
S D Kirley
P433issue4
P921main subjectkeratinocyteQ1473931
P304page(s)233-242
P577publication date1999-12-01
P1433published inThe ProstateQ7758608
P1476titleImmunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor
P478volume41

Reverse relations

cites work (P2860)
Q39249001AR Signaling and the PI3K Pathway in Prostate Cancer
Q35776234Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells
Q34057789Cultured stromal cells: an in vitro model of prostatic mesenchymal biology
Q40584336Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP.
Q39730653Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro
Q37258877Growth factors in benign prostatic hyperplasia: basic science implications
Q39498733Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells
Q34013858Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault
Q57107495New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors
Q34214409New concepts in the pathology of prostatic epithelial carcinogenesis.
Q36587375Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).
Q44785631Relationship between upregulated oestrogen receptors and expression of growth factors in cultured, human, prostatic stromal cells exposed to estradiol or dihydrotestosterone
Q42458008Studies on the differentiation pathway and growth characteristics of epithelial culture cells of the human prostate
Q37085226The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones
Q28076745The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance
Q40314994The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells
Q77359737Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate
Q44259286Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol

Search more.